Clinical trial

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

NCT05478031

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-06-07

PhasePHASE2

Study timeline

Study start (actual)2022-06-07Date precision: day

Registry last updated2025-12-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

REM0046127 High DoseDRUG

REM0046127 Low DoseDRUG

PlaceboDRUG

Sponsors & collaborators

reMYNDlead sponsor

Mapped research locations

BarcelonaSpain1 SevilleSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05478031 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.